Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLC

Fig. 5

Immune-related analysis of the prognostic score model high/low risk groups. (A) Immune function pathway analysis of prognostic score model; (B) Immune checkpoint analysis of the prognostic score model; (C) TME score of high/low risk group; (D) Heatmap of immune cell infiltration of the two groups; (E) Representative image of HE staining from the TCGA database showing the degree of immune cell infiltration of the two groups. (*P < 0.05; ** P < 0.01; and *** P < 0.001; Ns, not significant). TME, tumor microenvironment. TCGA, The Cancer Genome Atlas; HE, hematoxylin and eosin staining

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us